REFERENCES
- K. P. Akre, and V. G. Gaikar. (2006). Recovery of 1,4-dimethyl piperazine from aqueous solutions using polymeric adsorbent and ion-exchange resins. Sep. Sci. Technol. 41:1593–1617.
- W. L. F. Armarego, and D. D. Perrin. Purification of Laboratory Chemicals4th. Butterworth Heinemann Press, Oxford, (1996) .
- H. D. Beall, and K. B. Sloan. (2001). Topical delivery of 5-fluorouracil (5-FU) by 3-alkylcarbonyl-5-FU prodrugs. Int. J. Pharm. 217:127–137.
- F. P. Bonina, C. Puglia, T. Barbuzzi, P. D. Caprariis, F. Palagiano, M. G. Rimoli, and et al (2001). In vitro and in vivo evaluation of polyoxyethylene esters as dermal prodrugs of ketoprofen, naproxen and diclofenac. Eur. J. Pharm. Sci. 14:123–134.
- M. Buffum, and J. C. Buffum. (2000). Nonsteriodal anti-inflammatory drugs in elderly. Pain Manag. Nurs. 1:40–50.
- R. S. Chaudhary, S. S. Gangwal, K. C. Jindal, and S. Khanna. (1993). Reversed-phase high-performance liquid chromatography of ketorolac and its application to bioequivalence studies. J. Chromatogr. Biomed. Appl. 614:180–184.
- J. A. Cordero, L. Alarcon, E. Escribano, R. Obach, and J. Domenechx. (1997). A comparative study of the transdermal penetration of a series of nonsteroidal antiinflammatory drugs. J. Pharm. Sci. 86:503–508.
- H. J. Doh, W. J. Cho, C. S. Yong, H. G. Choi, J. S. Kim, C. H. Lee, and et al (2003). Synthesis and evaluation of ketorolac ester prodrugs for transdermal delivery. J. Pharm. Sci. 92:1008–1017.
- L. Fourie, J. C. Berytenbach, J. D. Plessis, C. Goosen, H. Swart, and J. Hadgraft. (2004). Percutaneous delivery of carbamazepine and selected N-Alkyl and N-Hydroxyalkyl Analogues. Int. J. Pharm. 279:59–66.
- B. Y. Kim, H. J. Doh, T. N. Le, W. J. Cho, C. S. Yong, H. G. Choi, and et al (2005). Ketorolac amide prodrugs for transdermal delivery: Stability and in vitro rat skin permeation studies. Int. J. Pharm. 293:193–202.
- C. Lin, W. Liao, K. Chen, and W. Lin. (2003). Influence of pH on electrophoretic behavior of phenothiazines and determination of pKa values by capillary zone electrophoresis. Electrophoresis 24:3154–3159.
- A. Macario, and A. G. Lipman. (2001). Ketorolac in the era of cyclo-oxygenase-2 selective nonsteroidal anti-inflammatory drugs: A systemic review of efficacy, side effects, and regulatory issues. Pain Med. 2:336–351.
- A. Mantyla, T. Garnier, J. Rautio, T. Nevalainen, J. Vepsalainen, A. Koskinen, and et al (2004). Synthesis, in vitro evaluation, and antileishmanial activity of water-soluble prodrugs of buparvaquone. J. Med. Chem. 47:188–195.
- J. M. Muchowski, S. H. Unger, J. Ackrell, P. Cheung, G. F. Cooper, J. Cook, and et al (1985). Synthesis and antiinflammatory and analgesic activity of 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acids and related compounds. J. Med. Chem. 28:1037–1049.
- C. Puglia, R. Filosa, A. Peduto, P. D. Caprariis, L. Rizza, F. Bonina, and et al (2006). Evaluation of alternative strategies to optimize ketorolac transdermal delivery. AAPS PharmSciTech 7:E1–E9.
- A. M. Qandil, B. M. Tashtoush, B. M. Al-Taani, S. M. Al-Nabulsi, and F. Al-Zogoul. (2008). Simultaneous RP-LC determination of ketorolac and its piperazinylalkyl ester prodrugs. Chromatographia 67:287–291.
- J. Rautio, T. Nevalainen, H. Taipale, J. Vepsalainen, J. Gynther, K. Laine, and et al (2000a). Piperazinylalkyl prodrugs of naproxen improve in vitro skin permeation. Eur. J. Pharm. Sci. 11:157–163.
- J. Rautio, T. Nevalainen, H. Taipale, J. Vepsalainen, J. Gynther, K. Laine, and et al (2000b). Synthesis and in vitro evaluation of novel morpholinyl- and methylpiperazinylacyloxyalkyl prodrugs of 2-(6-Methoxy-2-naphthyl)prpionic acid (Naproxen) for topical drug delivery. J. Med. Chem. 43:1489–1494.
- J. Rautio, T. Nevalainen, H. Taipale, J. Vepsalainen, J. Gynther, T. Pedersen, and et al (1999). Synthesis and in vitro evaluation of aminoacyloxyalkyl esters of 2-(6-Methoxy-2-naphthyl)propionic acid as novel naproxen prodrugs for dermal drug delivery. Pharm. Res. 16:1172–1178.
- J. Rautio, H. Taipale, J. Gynther, J. Vepsalainen, T. Nevalainen, and T. Jarvinen. (1998). In vitro evaluation of acyloxyalkyl esters as dermal prodrugs of ketoprofen and naproxen. J. Pharm. Sci. 87:1622–1628.
- W. J. Roberts, and K. B. Sloan. (1999). Correlation of aqueous and lipid solubilities with flux of prodrugs of 5-flourouracil, theophylline, and 6-mercaptopurine: A potts-guy approach. J. Pharm. Sci. 88:515–522.
- S. D. Roy, and E. Manoukian. (1994). Permeability of ketorolac acid and its ester analogs (Prodrug) through human cadaver skin. J.Pharm. Sci. 83:1548–10553.
- Prodrugs: Topical and ocular drug delivery. K. B. Sloan. Marcel Dekker, New York, (1992) 53.
- J. Tomi, R. Jarkko, N. Tapio, T. Hannu, V. Jouko, and G. Jukka. (2001). Finland Patent No. Finnish Patent.
- Dermatological and transdermal formulations. K. A. Walters. Marcel Dekker, New York, (2002) 119.
- Z. Wang, and R. M. Avram. (2001). Determination of ketorolac in human plasma by reversed-phase high-performance liquid chromatography using solid phase extraction and ultraviolet detection. J. Chromatogr. B 755:383–386.